A substantial proportion of patients with chronic rhinosinusitis (CRS) remain partly controlled or uncontrolled despite endoscopic sinus surgery (ESS) and maximal medical therapy. For these difficult-to-treat cases, topical antibiotic irrigations have been proposed as an adjunctive therapy, particularly when delivered via large-volume, low-pressure systems that enhance sinus penetration post-ESS. Evidence on their efficacy and prescribing patterns in this population remains limited.
Objective
This study aims to evaluate the use and outcomes of topical antibiotic irrigations in patients with difficult-to-treat CRS.
Methods
A retrospective, multi-site cohort study was conducted across tertiary academic medical centers. Adult patients with persistent CRS symptoms despite bilateral full-house ESS and conventional postoperative medical management were included. Patients with cystic fibrosis or granulomatosis with polyangiitis were excluded. Demographic, clinical, and treatment data were collected. Primary outcomes were infection resolution at 8 weeks and changes in Sino-Nasal Outcome Test-22 (SNOT-22) scores.
Results
Sixty-seven patients met inclusion criteria. Mupirocin (41.8%), tobramycin (23.9%), and gentamicin (17.9%) were the most commonly prescribed agents. After 8 weeks, 62.7% of patients achieved infection clearance. Among 44 patients with SNOT-22 data, scores improved significantly from 34.8 ± 20.2 to 21.8 ± 14.7 (P < .001). Improvement in SNOT-22 scores was more pronounced in patients who cleared the infection compared to those who did not.
Conclusion
Large-volume topical antibiotic irrigations were associated with high infection resolution rates and clinically meaningful SNOT-22 improvements in patients with difficult-to-treat CRS. These findings support their potential utility as an adjunctive therapy in select postsurgical patients and warrant further prospective investigation.
LourijsenESReitsmaSVlemingM, et al.Endoscopic sinus surgery with medical therapy versus medical therapy for chronic rhinosinusitis with nasal polyps: a multicentre, randomised, controlled trial. Lancet Respir Med. 2022;10(4):337-346. doi:10.1016/S2213-2600(21)00457-4
2.
RudmikLSolerZM. Medical therapies for adult chronic sinusitis: a systematic review. JAMA. 2015;314(9):926-939. doi:10.1001/jama.2015.7544
3.
FokkensWJLundVJHopkinsC, et al.Executive summary of EPOS 2020 including integrated care pathways. Rhinology. 2020;58(2):82-111. doi:10.4193/Rhin20.601
4.
HuangTZhouJYuanFYanYWuD. The percentage of controlled chronic rhinosinusitis after treatment: a systematic review and meta-analysis. Eur Arch Otorhinolaryngol. 2024;281(5):2183-2194. doi:10.1007/s00405-023-08363-5
5.
van der VeenJSeysSFTimmermansM, et al.Real-life study showing uncontrolled rhinosinusitis after sinus surgery in a tertiary referral centre. Allergy. 2017;72(2):282-290. doi:10.1111/all.12983
6.
LeeVSDavisGE. Culture-directed topical antibiotic treatment for chronic rhinosinusitis. Am J Rhinol Allergy. 2016;30(6):414-417. doi:10.2500/ajra.2016.30.4380
7.
ChenBAntunesMBClaireSE, et al.Reversal of chronic rhinosinusitis-associated sinonasal ciliary dysfunction. Am J Rhinol. 2007;21(3):346-353. doi:10.2500/ajr.2007.21.3029
8.
ScaddingGKLundVJDarbyYC. The effect of long-term antibiotic therapy upon ciliary beat frequency in chronic rhinosinusitis. J Laryngol Otol. 1995;109(1):24-26. doi:10.1017/s0022215100129159
DesrosiersMYSalas-PratoM. Treatment of chronic rhinosinusitis refractory to other treatments with topical antibiotic therapy delivered by means of a large-particle nebulizer: results of a controlled trial. Otolaryngol Head Neck Surg. 2001;125(3):265-269. doi:10.1067/mhn.2001.117410
11.
SykesDAWilsonRChanKLMackayISColePJ. Relative importance of antibiotic and improved clearance in topical treatment of chronic mucopurulent rhinosinusitis. A controlled study. Lancet. 1986;328(8503):359-360. doi:10.1016/s0140-6736(86)90051-6
12.
FokkensWJLundVJHopkinsC, et al.European position paper on rhinosinusitis and nasal polyps 2020. Rhinol J. 2020;58(Suppl S29):1-464. doi:10.4193/Rhin20.600
13.
WeiCCAdappaNDCohenNA. Use of topical nasal therapies in the management of chronic rhinosinusitis. Laryngoscope. 2013;123(10):2347-2359. doi:10.1002/lary.24066
14.
HarveyRJSnidvongsKKalishLHOakleyGMSacksR. Corticosteroid nasal irrigations are more effective than simple sprays in a randomized double-blinded placebo-controlled trial for chronic rhinosinusitis after sinus surgery. Int Forum Allergy Rhinol. 2018;8(4):461-470. doi:10.1002/alr.22093
15.
Martinez-ParedesJFChobyGMarinoM, et al.Endoscopic outcomes in patients with AERD treated with topical antibiotics and intranasal corticosteroids. Front Cell Infect Microbiol. 2022;12:812215. doi:10.3389/fcimb.2022.812215
16.
WhiteheadRATalatiVBairdAM, et al.The efficacy of mupirocin nasal irrigations for treatment of refractory chronic rhinosinusitis after endoscopic sinus surgery. Am J Rhinol Allergy. 2025;39:364-370. doi:10.1177/19458924251343389
17.
OrlandiRRKingdomTTSmithTL, et al.International Consensus Statement on Allergy and Rhinology: Rhinosinusitis 2021. Int Forum Allergy Rhinol. 2021;11(3):213-739. doi:10.1002/alr.22741
18.
AthniTSBarmettlerS. Hypogammaglobulinemia, late-onset neutropenia, and infections following rituximab. Ann Allergy Asthma Immunol. 2023;130(6):699-712. doi:10.1016/j.anai.2023.01.018
19.
LuterbacherFBernardFBaleydierFRanzaEJandusPBlanchard-RohnerG. Case report: persistent hypogammaglobulinemia more than 10 years after rituximab given post-HSCT. Front Immunol. 2021;12:773853. doi:10.3389/fimmu.2021.773853
20.
HopkinsCGillettSSlackRLundVJBrowneJP. Psychometric validity of the 22-item Sinonasal Outcome Test. Clin Otolaryngol. 2009;34(5):447-454. doi:10.1111/j.1749-4486.2009.01995.x
21.
BonfilsPEscabasseVCosteA, et al.Efficacy of tobramycin aerosol in nasal polyposis. Eur Ann Otorhinolaryngol Head Neck Dis. 2015;132(3):119-123. doi:10.1016/j.anorl.2015.03.008
22.
VidelerWJvan DrunenCMReitsmaJBFokkensWJ. Nebulized bacitracin/colimycin: a treatment option in recalcitrant chronic rhinosinusitis with Staphylococcus aureus? A double-blind, randomized, placebo-controlled, cross-over pilot study. Rhinology. 2008;46(2):92-98.
23.
LamKTanBKLavinJMMeenEConleyDB. Comparison of nasal sprays and irrigations in the delivery of topical agents to the olfactory mucosa. Laryngoscope. 2013;123(12):2950-2957. doi:10.1002/lary.24239
24.
MuenkaewYTangbumrungthamNRoongpuvapahtBTanjararakK. Comparison of sinus distribution between nasal irrigation and nasal spray using fluorescein-labelled in patients with chronic rhinosinusitis: a randomised clinical trial. Clin Otolaryngol. 2023;48(2):286-293. doi:10.1111/coa.13951
25.
PourmehranOPsaltisAVreugdeS, et al.Evaluating nebulisation and nasal irrigation efficiency in post-operative chronic rhinosinusitis patients through computational fluid dynamics simulation. Comput Methods Programs Biomed. 2025;264:108697. doi:10.1016/j.cmpb.2025.108697
26.
WormaldPJCainTOatesLHawkeLWongI. A comparative study of three methods of nasal irrigation. Laryngoscope. 2004;114(12):2224-2227. doi:10.1097/01.mlg.0000149463.95950.c5
27.
JuniperEFThompsonAKFerriePJRobertsJN. Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire. J Allergy Clin Immunol. 1999;104(2 Pt 1):364-369. doi:10.1016/s0091-6749(99)70380-5
28.
ConstantinouCYapDPervaizA, et al.Comparison of intranasal medication delivery devices before and after functional endoscopic sinus surgery using Phacon sinus surgery models. J Laryngol Otol. 2024;138(3):310-314. doi:10.1017/S0022215123001226
29.
de Paiva LeiteSHDouglasRG. How does sinus surgery affect topical irrigation distribution?Curr Opin Otolaryngol Head Neck Surg. 2018;26(1):21-26. doi:10.1097/MOO.0000000000000429
30.
HarveyRJGoddardJCWiseSKSchlosserRJ. Effects of endoscopic sinus surgery and delivery device on cadaver sinus irrigation. Otolaryngol Head Neck Surg. 2008;139(1):137-142. doi:10.1016/j.otohns.2008.04.020
31.
MollerWSchuschnigUCelikG, et al.Topical drug delivery in chronic rhinosinusitis patients before and after sinus surgery using pulsating aerosols. PLoS One. 2013;8(9):e74991. doi:10.1371/journal.pone.0074991
32.
ZhaoKCraigJRCohenNAAdappaNDKhaliliSPalmerJN. Sinus irrigations before and after surgery-visualization through computational fluid dynamics simulations. Laryngoscope. 2016;126(3):E90-E96. doi:10.1002/lary.25666
33.
AntunesMBFeldmanMDCohenNAChiuAG. Dose-dependent effects of topical tobramycin in an animal model of Pseudomonas sinusitis. Am J Rhinol. 2007;21(4):423-427. doi:10.2500/ajr.2007.21.3046
34.
LeonardDWBolgerWE. Topical antibiotic therapy for recalcitrant sinusitis. Laryngoscope. 1999;109(4):668-670. doi:10.1097/00005537-199904000-00029
35.
UrenBPsaltisAWormaldPJ. Nasal lavage with mupirocin for the treatment of surgically recalcitrant chronic rhinosinusitis. Laryngoscope. 2008;118(9):1677-1680. doi:10.1097/MLG.0b013e31817aec47
36.
Jervis-BardyJBoaseSPsaltisAForemanAWormaldPJ. A randomized trial of mupirocin sinonasal rinses versus saline in surgically recalcitrant staphylococcal chronic rhinosinusitis. Laryngoscope. 2012;122(10):2148-2153. doi:10.1002/lary.23486
37.
HaKRPsaltisAJButcherARWormaldPJTanLW. In vitro activity of mupirocin on clinical isolates of Staphylococcus aureus and its potential implications in chronic rhinosinusitis. Laryngoscope. 2008;118(3):535-540. doi:10.1097/MLG.0b013e31815bf2e3
38.
LeTPsaltisATanLWWormaldPJ. The efficacy of topical antibiofilm agents in a sheep model of rhinosinusitis. Am J Rhinol. 2008;22(6):560-567. doi:10.2500/ajr.2008.22.3232
39.
PhillipsKMHoehleLPCaradonnaDSGraySTSedaghatAR. Minimal clinically important difference for the 22-item Sinonasal Outcome Test in medically managed patients with chronic rhinosinusitis. Clin Otolaryngol. 2018;43(5):1328-1334. doi:10.1111/coa.13177
40.
PhillipsKMHousseinFABoeckermannLMSingermanKWLiuDTSedaghatAR. Multi-institutional minimal clinically important difference of the 22-item Sinonasal Outcome Test in medically managed chronic rhinosinusitis. Rhinol J. 2021;59(6):552-559. doi:10.4193/Rhin21.253
41.
SpethMMGaudinRAHoehleLP, et al.Reciprocal predictive accuracy of sinonasal symptom severity, nasal endoscopy, and frequency of past chronic rhinosinusitis exacerbations. Otolaryngol Head Neck Surg. 2018;159(4):766-773. doi:10.1177/0194599818774741
42.
KatoAKitaH. The immunology of asthma and chronic rhinosinusitis. Nat Rev Immunol. 2025;25(8):569-587. doi:10.1038/s41577-025-01159-0
